July 03, 2025

MasSpec Pen Detects Opioids; a Kidney Lipid Atlas; Synthesis Spotlight

And more cutting-edge mass spec research…

The Analytical Scientist

July 03, 2025

Honoring FT-ICR Pioneer Alan G. Marshall (1944–2025)

Co-inventor of FT-ICR mass spectrometry, Alan G. Marshall advanced high-resolution analysis and trained over 100 scientists during his five-decade career

The Analytical Scientist

July 02, 2025

ADA extends Well-Being Index to dental team members

The index is an anonymous, validated assessment and measurement tool developed by Mayo Clinic to address clinician distress and well-being.

ADA News

July 02, 2025

‘Never been cooler’: Metal braces making comeback with help from social media

Former brace faces rejoice — a look that may have once been considered “uncool” is now trending among today’s orthodontic patients.

ADA News

July 02, 2025

Medical Oddities: Leprosy’s Old New World Secret

This week’s clinical grab bag: tea for gloom, ancient leprosy, smoggy fibrosis & power peeing.

Conexiant

July 02, 2025

Meet Spectroscopy’s “New School”

How compact, connected, and consumer-ready technologies are taking spectroscopy out of the lab and into the world

The Analytical Scientist

July 02, 2025

UK Plans Nationwide DNA Sequencing of Newborns

The scheme aims to prevent disease, but some experts are skeptical

The Analytical Scientist

July 02, 2025

Dispelling Dry Eye Delusions

Educational campaign aims to dispel misconceptions around the condition

The Ophthalmologist

July 02, 2025

Can Genetic Testing Identify the Best Treatment for Metastatic, Castration-Resistant Prostate Cancer?

Patients with metastatic, castration-resistant prostate cancer (mCRPC) have a median overall survival of only about two to three years, but genomic sequencing is making inroads against that grim prognosis.

Roswell Park Comprehensive Cancer Center